[1]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660
|
[2]
|
李聪, 徐兵河. 肿瘤干细胞临床应用研究进展[J]. 中国癌症防治杂志, 2021, 13(1): 1-6.
|
[3]
|
杨婷, 冉宇靓. 靶向肿瘤干细胞治疗肿瘤[J]. 中国肿瘤生物治疗杂志, 2021, 28(7): 651-658.
|
[4]
|
丁博月, 韩春. 结直肠癌干细胞表面标志物和信号通路研究进展[J]. 基础医学与临床, 2017, 37(1): 133-137.
|
[5]
|
Kuhlmann, J.D., Hein, L., Kurth, I., et al. (2016) Targeting Cancer Stem Cells Promises and Challenges. Anti-Cancer Agents in Medicinal Chemistry, 16, 38-58.
|
[6]
|
Chang, J.C. (2016) Cancer Stem Cells: Role in Tumor Growth, Recurrence, Metastasis, and Treatment Resistance. Medicine, 95, S20-S25. https://doi.org/10.1097/MD.0000000000004766
|
[7]
|
张家媛, 李楚荞, 黄淑敏, 等. 富亮氨酸重复结构在结直肠癌发病机制中作用的研究进展[J]. 国际消化病杂志, 2020, 40(4): 227-230.
|
[8]
|
Fu, T., Coulter, S., Yoshihara, E., et al. (2019) FXR Regulates Intestinal Cancer Stem Cell Proliferation. Cell, 176, 1098-1112. https://doi.org/10.1016/j.cell.2019.01.036
|
[9]
|
Arkadiusz, G., Izabela, Z., Damian, J., et al. (2020) The Prognostic Value of Leucine-Rich Repeat-Containing G-Protein (Lgr5) and Its Impact on Clinicopathological Features of Colorectal Cancer. Journal of Cancer Research and Clinical Oncology, 146, 2547-2557.
|
[10]
|
Xu, N., Gao, K., Luo, H., et al. (2021) Correlation of Lgr5 Expression with Clinicopathological Features of Colorectal Cancer and Its Diagnostic and Prognostic Values. Journal of BUON, 26, 87-92.
|
[11]
|
Jang, B.G., Kim, H.S., Chang, W.Y., et al. (2018) Expression Profile of LGR5 and Its Prognostic Significance in Colorectal Cancer Progression. The American Journal of Pathology, 188, 2236-2250.
https://doi.org/10.1016/j.ajpath.2018.06.012
|
[12]
|
Zheng, J.H., Xu, L.X., Pan, Y.B., et al. (2017) Sox2 Modulates Motility and Enhances Progression of Colorectal Cancer via the Rho-ROCK Signaling Pathway. Oncotarget, 8, 98635-98645. https://doi.org/10.18632/oncotarget.21709
|
[13]
|
Zhu, Y., Huang, S.M., Chen, S.Y., et al. (2021) Sox2 Promotes Chemoresistance, Cancer Stem Cells Properties, and Epithelial-Mesenchymal Transition by β-Catenin and Beclin1/Autophagy Signaling in Colorectal Cancer. Cell Death & Disease, 12, Article No. 449. https://doi.org/10.1038/s41419-021-03733-5
|
[14]
|
郑媛媛, 陈黎, 谭海花, 等. Sox2在结直肠癌组织中的表达及其临床特征的Meta分析[J]. 海南医学, 2020, 31(11): 1481-1485.
|
[15]
|
Hoskovec, D. (2014) Perioperative Chemotherapy in Gastric Cancer Treatment—The Surgeons View. Casopís Lékar̆ů C̆eských, 153, 227-230.
|
[16]
|
王利康, 姜雷, 王军, 等. EpCAM与结直肠癌临床病理特征关系的meta分析[J]. 中国普外基础与临床杂志, 2021, 28(5): 571-579.
|
[17]
|
Eyvazi, S., Farajnia, S., Dastmalchi, S., et al. (2018) Antibody Based EpCAM Targeted Therapy of Cancer, Review and Update. Current Cancer Drug Targets, 18, 857-868. https://doi.org/10.2174/1568009618666180102102311
|
[18]
|
Liao, M.Y., Lai, J.K., Kuo, M.Y., et al. (2015) An Anti-EpCAM Antibody EpAb2-6 for the Treatment of Colon Cancer. Oncotarget, 6, 24947-24968. https://doi.org/10.18632/oncotarget.4453
|
[19]
|
Dirix, L., Rüttinger, D., Schuler, M., Reinhardt, C., et al. (2010) An Open-Label, Randomized Phase II Study of Adecatumumab, a Fully Human Anti-EpCAM Antibody, as Monotherapy in Patients with Metastatic Breast Cancer. Annals of Oncology, 21, 275-282. https://doi.org/10.1093/annonc/mdp314
|
[20]
|
Yu, F., Zhou, C., Zeng, H., et al. (2018) BMI1 Activates WNT Signaling in Colon Cancer by Negatively Regulating the WNT Antagonist IDAX. Biochemical and Biophysical Research Communications, 496, 468-474.
https://doi.org/10.1016/j.bbrc.2018.01.063
|
[21]
|
Zhang, Z., Bu, X., Chen, H., et al. (2016) Bmi-1 Promotes the Invasion and Migration of Colon Cancer Stem Cells through the Downregulation of E-Cadherin. International Journal of Molecular Medicine, 38, 1199-1207.
https://doi.org/10.3892/ijmm.2016.2730
|
[22]
|
卢敏, 郑相涛, 毛华, 等. 基于GEO数据库对结肠癌BMI1基因筛选及其对人结肠癌细胞增殖及侵袭迁移机制研究[J]. 实用医学杂志, 2020, 36(10): 1292-1298.
|
[23]
|
Zhang, J., Li, Q. and Chang, A.E. (2019) Immunologic Targeting of Cancer Stem Cells. Surgical Oncology Clinics, 28, 431-445. https://doi.org/10.1016/j.soc.2019.02.010
|
[24]
|
彭立雄, 常江, 张博威, 等. LGR5在结直肠癌中的作用机制及靶向治疗研究进展[J]. 生命科学, 2021, 33(10): 1231-1238.
|
[25]
|
Azhdarinia, A., Voss, J., Ghosh, S.C., et al. (2018) Evaluation of Anti-LGR5 Antibodies by ImmunoPET for Imaging Colorectal Tumors and Development of Antibody-Drug Conjugates. Molecular Pharmaceutics, 15, 2448-2554.
https://doi.org/10.1021/acs.molpharmaceut.8b00275
|
[26]
|
员亚晶, 徐利晓, 孙斌, 等. RNAi沉默Sox2表达对结直肠癌细胞5-氟尿嘧啶的增敏作用[J]. 江苏大学学报(医学版), 2020, 30(1): 7-11+17.
|
[27]
|
Pan, Q., Li, Q., Liu, S., et al. (2015) Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches. Stem Cells, 33, 2085-2092. https://doi.org/10.1002/stem.2039
|